Ryan Mork

Ryan Mork, Director of Data Science at Evozyne, shares insights on using generative AI for therapeutic protein design. He discusses how Evozyne combines large language models with evolutionary history to create new biomolecules. Ryan highlights the challenges of model evaluation and the critical collaboration between wet lab and data science teams. He also envisions the future of AI in biotechnology, emphasizing the role of human insight in advancing drug development and the ongoing innovative projects at Evozyne.